(258 days)
Not Found
No
The device description details a purely mechanical, pneumatically powered lithotripter. There is no mention of any computational or data-driven components that would suggest the use of AI or ML. The "Mentions AI, DNN, or ML" and "Description of the training set..." sections are also explicitly marked as "Not Found".
Yes
The device is described as an "intracorporeal lithotripter" intended for the "fragmentation of urinary tract (i.e. kidney, ureter and bladder) stones," which is a medical intervention to treat a disease condition (kidney stones).
No
The device is described as a lithotripter used for fragmentation of urinary tract stones, which is a therapeutic function, not a diagnostic one.
No
The device description clearly outlines a physical, non-electrical, pneumatic device powered by a gas cartridge, with probes and an exhaust line. There is no mention of software as a component or the primary function of the device.
Based on the provided information, the LMA StoneBreaker™ is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- LMA StoneBreaker™ Function: The LMA StoneBreaker™ is a device used within the body (intracorporeal) to physically fragment stones in the urinary tract. It directly interacts with the stone inside the patient.
- Intended Use: The intended use clearly states it's for "fragmentation of urinary tract... stones" via an endoscope. This is a therapeutic procedure, not a diagnostic test performed on a specimen outside the body.
Therefore, the LMA StoneBreaker™ is a therapeutic medical device, not an IVD.
N/A
Intended Use / Indications for Use
The LMA StoneBreaker™ is indicated for use via a rigid or semi-rigid endoscope with a straight working channel, for the fragmentation of urinary tract (i.e. kidney, ureter and bladder) stones.
Product codes (comma separated list FDA assigned to the subject device)
FFK
Device Description
The LMA StoneBreaker™ is a portable, non-electrical, pneumatic contact intracorporeal lithotripter, intended for use to fragment stones in the urinary tract (i.e. kidney, ureter and bladder). Its weight of approximately 500g with a probe, and with no extraneous electrical or pneumatic connections, makes this device highly portable. It is recommended for use with endoscopes equipped with a straight working channel. The device is powered by a detachable cartridge of high pressure carbon dioxide gas, with a maximum pre-adjusted operating pressure of 31 bars. The mechanical shock generated by the device is transferred through the length of the probe to the tip, which is in direct contact with the stone to be fragmented, providing high speed fragmentation of the calculus in situ.
Three sizes of probe (1.0mm, 1.6mm and 2.0mm) are available for use with the LMA StoneBreaker™
A LMA StoneBreaker™ Carbon Dioxide (CO2) gas cartridge provides the necessary energy for one surgical procedure. Once the cartridge is perforated by the built-in screw system, the compressed gas passes through a pre-adjusted pressure regulator in the device and a mechanical shockwave required for fragmentation of urinary stone is generated when the trigger is depressed.
Expended gas will leave the device through a specially designed exhaust port and the attached exhaust line The trigger snaps back to its starting position when the gas is expended through the exhaust port, and the device is now ready for further use.
The LMA StoneBreaker™, Probes, Exhaust Line and accessories are delivered non-sterile and it must be cleaned, disinfected and sterilized before initial use and before each subsequent use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
urinary tract (i.e. kidney, ureter and bladder)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance and clinical data are shown in Section 2. The operational, technological and clinical data demonstrate that the LMA StoneBreaker™ is substantially equivalent in safety and effectiveness to that of the predicated devices cited above.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.4480 Electrohydraulic lithotriptor.
(a)
Identification. An electrohydraulic lithotriptor is an AC-powered device used to fragment urinary bladder stones. It consists of a high voltage source connected by a cable to a bipolar electrode that is introduced into the urinary bladder through a cystoscope. The electrode is held against the stone in a water-filled bladder and repeated electrical discharges between the two poles of the electrode cause electrohydraulic shock waves which disintegrate the stone.(b)
Classification. Class II. The special control for this device is FDA's “Guidance for the Content of Premarket Notifications for Intracorporeal Lithotripters.”
0
Image /page/0/Picture/0 description: The image shows the text "K062475 pg. 1 of 3". The text appears to be handwritten. The text is black and the background is white.
The Laryngeal Mask Company Limited
510(K) SUMMARY
MAY - 9 2007
1. Manufacturer Information
The Laryngeal Mask Company Limited Le Rocher, Victoria, Mahe, Seychelles
| Contact Person: | Shirley Sum
Director, Regulatory Affairs and Quality Assurance |
|-----------------|----------------------------------------------------------------------|
| Tel No.: | +65 6349 1950 |
| Fax No.: | +65 6349 1959 |
| US Agent: | Foster Boop
Technical Affairs Director
LMA North America, Inc. |
| Tel No.: | (858) 622 5621 |
| Fax No.: | (858) 622 4147 |
Date Prepared: 03 August 2006
2. Device Information
2.1 Proposed Device
| Trade Name: | LMA StoneBreaker™ |
|---|---|
| Common Name: | Endoscopic intracorporeal pneumatic |
| lithotriptor | |
| Device Type: | Electrohydraulic lithotripter |
| Classification: | Class II |
| Product Code: | FFK |
| CFR Number: | 21 CFR 876.4480 |
・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・
:
1
Image /page/1/Picture/0 description: The image shows handwritten text on a white background. The first line contains the alphanumeric string "K 0624 75". The second line reads "pg 2 of 3", indicating it is page 2 of a 3-page document. The handwriting appears to be somewhat cursive and slightly faded.
The Laryngeal Mask Company Limited
510(K) SUMMARY
2.2 Predicate Device
- Predicate 1: Swiss LithoClast® (for fragmentation of ureteral and bladder stones) already marketed in the USA under K951531
- Predicate 2: Swiss LithoClast® (for fragmentation of ureteral, bladder and kidney stones) already marketed in the USA under K963285
- Predicate 3: Swiss LithoClast® Master already marketed in the USA under K974164
Device Description 3.
The LMA StoneBreaker™ is a portable, non-electrical, pneumatic contact intracorporeal lithotripter, intended for use to fragment stones in the urinary tract (i.e. kidney, ureter and bladder). Its weight of approximately 500g with a probe, and with no extraneous electrical or pneumatic connections, makes this device highly portable. It is recommended for use with endoscopes equipped with a straight working channel. The device is powered by a detachable cartridge of high pressure carbon dioxide gas, with a maximum pre-adjusted operating pressure of 31 bars. The mechanical shock generated by the device is transferred through the length of the probe to the tip, which is in direct contact with the stone to be fragmented, providing high speed fragmentation of the calculus in situ.
Three sizes of probe (1.0mm, 1.6mm and 2.0mm) are available for use with the LMA StoneBreaker™
A LMA StoneBreaker™ Carbon Dioxide (CO2) gas cartridge provides the necessary energy for one surgical procedure. Once the cartridge is perforated by the built-in screw system, the compressed gas passes through a pre-adjusted pressure regulator in the device and a mechanical shockwave required for fragmentation of urinary stone is generated when the trigger is depressed.
Expended gas will leave the device through a specially designed exhaust port and the attached exhaust line The trigger snaps back to its starting
LMA StoneBreaker ™
2
Image /page/2/Picture/0 description: The image shows the logo for "The Laryngeal Mask Company Limited". The logo consists of the letters "LMA" in large, bold, black font on the top line. Below that, in a smaller font, is the text "The Laryngeal Mask Company Limited".
Image /page/2/Picture/1 description: The image shows handwritten text. The first line reads "K 062475". The second line reads "Pg 2 of 3". The text appears to be a page number or document identifier.
510(K) SUMMARY
position when the gas is expended through the exhaust port, and the device is now ready for further use.
The LMA StoneBreaker™, Probes, Exhaust Line and accessories are delivered non-sterile and it must be cleaned, disinfected and sterilized before initial use and before each subsequent use.
4. Intended Use
The LMA StoneBreaker™ is indicated for use via a rigid or semi-rigid endoscope with a straight working channel, for the fragmentation of urinary tract (i.e. kidney, ureter and bladder) stones.
Basis for Substantial Equivalence to Predicate Devices 6.
The proposed device is substantially equivalent to predicate devices Swiss LithoClast® and Swiss LithoClast® Master, which were previously cleared for intracorporeal fragmentation of ureteral and bladder stones under K951531, for kidney stones under K963285 and for kidney, ureteral and bladder stones under K974164. The main differences between the LMA StoneBreaker™ and predicate devices are:
- · Portability The proposed device is hand-held portable lithotripter. Predicate devices are non-portable lithotripter.
- · Energy Source The proposed device is powered by detachable Carbon dioxide gas cartridge. Predicate devices are powered by connection to compressed air.
Performance Characteristics 6.
Performance and clinical data are shown in Section 2. The operational, technological and clinical data demonstrate that the LMA StoneBreaker™ is substantially equivalent in safety and effectiveness to that of the predicated devices cited above.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three wavy lines that form an abstract human figure.
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
The Laryngeal Mask Company Ltd. c/o Mr. Foster Boop Technical Affairs Director LMA" North America, Inc. 4660 La Jolla Village Drive, Suite 900 SAN DIEGO CA 92122
MAY - 9 2007
Re: K062475
Trade/Device Name: LMA StoneBreaker" Regulation Number: 21 CFR §876.4480 Regulation Name: Electrohydraulic lithotripter Regulatory Class: II Product Code: FFK Dated: March 13, 2007 Received: March 14, 2007
Dear Mr. Boop:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/3/Picture/10 description: The image is a circular logo or seal. The text "1906-2006" is at the top of the logo. The letters "FDA" are in the center of the logo, with the word "Centennial" underneath. The words "Food & Drug Administration" are around the perimeter of the logo.
coling and Promoting Public S
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) 1 premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use Statement
Applicant:
The Laryngeal Mask Company Limited
510(k) Number (if known):
Device Name:
LMA StoneBreaker™
Indications for Use:
The LMA StoneBreaker™ is indicated for use via a rigid or semi-rigid endoscope with a straight working channel, for the fragmentation of urinary tract (i.e. kidney, ureter and bladder) stones.
Prescription Use レ (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nancyc brogdon
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number. K062475/